106 related articles for article (PubMed ID: 12909202)
1. SL65.0472 blocks 5-hydroxytryptamine-induced vasoconstriction in a dog hindlimb ischemia model.
Barbe F; Gautier E; Bidouard JP; Grosset A; O'Connor SE; Janiak P
Eur J Pharmacol; 2003 Aug; 474(1):117-20. PubMed ID: 12909202
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular effects of SL65.0472, a 5-HT receptor antagonist.
O'Connor SE; Grosset A; La Rochelle CD; Gautier E; Bidouard JP; Robineau P; Caille D; Janiak P
Eur J Pharmacol; 2001 Mar; 414(2-3):259-69. PubMed ID: 11239927
[TBL] [Abstract][Full Text] [Related]
3. Serotonin receptor blockade improves distal perfusion after lower limb ischemia in the fatty Zucker rat.
Janiak P; Lainée P; Grataloup Y; Luyt CE; Bidouard JP; Michel JB; O'Connor SE; Herbert JM
Cardiovasc Res; 2002 Nov; 56(2):293-302. PubMed ID: 12393100
[TBL] [Abstract][Full Text] [Related]
4. Serotonin aggravates exercise-induced cardiac ischemia in the dog: effect of serotonin receptor antagonists.
Guilbert F; Lainée P; Dubreuil B; McCort G; O'Connor SE; Janiak P; Herbert JM
Eur J Pharmacol; 2004 Aug; 497(1):55-63. PubMed ID: 15321735
[TBL] [Abstract][Full Text] [Related]
5. Antiplatelet and antithrombotic activity of SL65.0472, a mixed 5-HT1B/5-HT2A receptor antagonist.
Berry CN; Lorrain J; Lochot S; Delahaye M; Lalé A; Savi P; Lechaire I; Ferrari P; Bernat A; Schaeffer P; Janiak P; Duval N; Grosset A; Herbert JM; O'Connor SE
Thromb Haemost; 2001 Mar; 85(3):521-8. PubMed ID: 11307825
[TBL] [Abstract][Full Text] [Related]
6. Modulation of vasoactivity and platelet aggregation by selective 5-HT receptor antagonism in humans.
Moerland M; Kemme M; Dijkmans A; Bergougnan L; Burggraaf J
J Cardiovasc Pharmacol; 2011 Dec; 58(6):575-80. PubMed ID: 21822145
[TBL] [Abstract][Full Text] [Related]
7. Effects of SL 65.0472, a novel 5-HT receptor antagonist, on 5-HT receptor mediated vascular contraction.
Galzin AM; Delahaye M; Hoornaert C; McCort G; O'Connor SE
Eur J Pharmacol; 2000 Sep; 404(3):361-8. PubMed ID: 10996601
[TBL] [Abstract][Full Text] [Related]
8. The GR127935-sensitive 5-HT(1) receptors mediating canine internal carotid vasoconstriction: resemblance to the 5-HT(1B), but not to the 5-HT(1D) or 5-ht(1F), receptor subtype.
Centurión D; Sánchez-López A; De Vries P; Saxena PR; Villalón CM
Br J Pharmacol; 2001 Mar; 132(5):991-8. PubMed ID: 11226129
[TBL] [Abstract][Full Text] [Related]
9. Vasodilator and vasoconstrictor responses induced by 5-hydroxytryptamine in the in situ blood autoperfused hindquarters of the anaesthetized rat.
Calama E; Fernández MM; Morán A; Martín ML; San Román L
Naunyn Schmiedebergs Arch Pharmacol; 2002 Aug; 366(2):110-6. PubMed ID: 12122496
[TBL] [Abstract][Full Text] [Related]
10. External carotid effects of 2-(2-aminoethyl)-quinoline (D-1997) in vagosympathectomized dogs.
Villalón CM; López-Muñoz FJ; Perusquía M; Terrón JA
Eur J Pharmacol; 1998 Aug; 356(1):15-23. PubMed ID: 9761419
[TBL] [Abstract][Full Text] [Related]
11. Evidence for 5-HT(1B/1D) and 5-HT(2A) receptors mediating constriction of the canine internal carotid circulation.
Centurión D; Ortiz MI; Sánchez-López A; De Vries P; Saxena PR; Villalón CM
Br J Pharmacol; 2001 Mar; 132(5):983-90. PubMed ID: 11226128
[TBL] [Abstract][Full Text] [Related]
12. Vasoconstrictor responses to 5-hydroxytryptamine in the autoperfused hindquarters of spontaneously hypertensive rats.
Calama E; Morán A; Ortiz de Urbina AV; Martín ML; San Román L
Pharmacology; 2004 Jun; 71(2):66-72. PubMed ID: 15118345
[TBL] [Abstract][Full Text] [Related]
13. 5-Hydroxytryptamine1B receptor-mediated contraction of rabbit saphenous vein and basilar artery: role of vascular endothelium.
Bhattacharya A; Schenck KW; Xu YC; Nisenbaum L; Galbreath E; Cohen ML
J Pharmacol Exp Ther; 2004 May; 309(2):825-32. PubMed ID: 14724223
[TBL] [Abstract][Full Text] [Related]
14. m-CPP, a 5-HT2C receptor agonist that modifies the perfusion pressure of the hindquarter vascular bed of anesthetized rat.
Calama E; Morán A; Ortiz de Urbina AV; Martín ML; San Román L
Pharmacology; 2005 Feb; 73(2):70-5. PubMed ID: 15452415
[TBL] [Abstract][Full Text] [Related]
15. 5-HT receptors mediating external carotid vasoconstriction in vagosympathectomized dogs.
Villalón CM; Centurión D; Sánchez-López A; De Vries P; Saxena P
Zhongguo Yao Li Xue Bao; 1999 Dec; 20(12):1057-67. PubMed ID: 11216445
[TBL] [Abstract][Full Text] [Related]
16. 5-hydroxytryptamine receptors mediating vasoconstriction and vasodilation in perinatal and adult rabbit small pulmonary arteries.
Morecroft I; MacLean MR
Br J Pharmacol; 1998 Sep; 125(1):69-78. PubMed ID: 9776346
[TBL] [Abstract][Full Text] [Related]
17. GR127935 is a potent antagonist of the 5-HT1-like receptor mediating contraction in the canine coronary artery.
Terrón JA
Eur J Pharmacol; 1996 Apr; 300(1-2):109-12. PubMed ID: 8741174
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological profile of the receptors that mediate external carotid vasoconstriction by 5-HT in vagosympathectomized dogs.
Villalón CM; Ramírez-San Juan E; Castillo C; Castillo E; López-Muñoz FJ; Terrón JA
Br J Pharmacol; 1995 Nov; 116(6):2778-84. PubMed ID: 8591004
[TBL] [Abstract][Full Text] [Related]
19. The canine external carotid vasoconstrictor 5-HT1 receptor: blockade by 5-HT1B (SB224289), but not by 5-HT1D (BRL15572) receptor antagonists.
De Vries P; Sánchez-López A; Centurión D; Heiligers JP; Saxena PR; Villalón CM
Eur J Pharmacol; 1998 Nov; 362(1):69-72. PubMed ID: 9865532
[TBL] [Abstract][Full Text] [Related]
20. Role of serotonin in angiogenesis: induction of angiogenesis by sarpogrelate via endothelial 5-HT1B/Akt/eNOS pathway in diabetic mice.
Iwabayashi M; Taniyama Y; Sanada F; Azuma J; Iekushi K; Kusunoki H; Chatterjee A; Okayama K; Rakugi H; Morishita R
Atherosclerosis; 2012 Feb; 220(2):337-42. PubMed ID: 22172591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
